Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp (AHCO) delivers essential home medical equipment and healthcare-at-home services, empowering patients through respiratory care, mobility solutions, and chronic condition management. This page provides centralized access to all official company announcements and market-relevant developments.
Investors and healthcare professionals will find timely updates on earnings reports, regulatory milestones, product launches, and strategic partnerships. Our curated collection includes press releases on sleep therapy innovations, respiratory equipment advancements, and operational expansions across AHCO's nationwide network.
Key areas covered include quarterly financial results, clinical service enhancements, Medicare/Medicaid compliance updates, and technology integrations in home healthcare. All content is sourced directly from AdaptHealth's communications to ensure accuracy and relevance for stakeholders.
Bookmark this page for streamlined access to AHCO's latest business developments. Check regularly for updates impacting the home healthcare sector and AdaptHealth's position within this critical industry.
AdaptHealth Corp. (NASDAQ: AHCO) announced participation in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 11 at 12:40 pm PT. CEO Steve Griggs and CFO Jason Clemens will lead the discussion, which can be accessed via a live webcast on AdaptHealth's website. The company is a leader in providing patient-centered healthcare-at-home solutions, serving approximately 3.8 million patients annually across the U.S. through over 750 locations. This includes services for chronic conditions like sleep apnea and diabetes.
AdaptHealth Corp. (NASDAQ: AHCO) will release its Q1 2022 financial results on May 10, 2022, before market opening. A teleconference will follow at 8:30 a.m. ET for discussions regarding the results and business activities. This company is a leader in patient-centered healthcare-at-home solutions, offering products like sleep therapy equipment, diabetes supplies, and oxygen services through a network covering approximately 3.8 million patients in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) reported exceptional results for 2021, with revenues soaring to $2.45 billion, more than double the $1.06 billion from 2020. The company serves around 3.8 million patients annually, despite facing challenges from CPAP shortages. The fourth quarter revenue reached a record $702.1 million, marking a 102% increase year-over-year. Net income for the quarter was $22.9 million, a significant recovery from a net loss of $80.5 million in Q4 2020. AdaptHealth updated its 2022 guidance, expecting revenues between $2.825 billion and $3.025 billion.
AdaptHealth Corp. (NASDAQ: AHCO) announced that its CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the SVB Leerink Global Healthcare Conference on February 18 at 9:20 am ET. A live webcast and replay will be available on the Investors section of AdaptHealth's website. AdaptHealth is a leader in providing home healthcare solutions, serving approximately 3.6 million patients across 50 states with a range of medical products and services.
AdaptHealth Corp. (NASDAQ: AHCO) will release its Q4 and full year 2021 financial results on February 24, 2022, before market opening. A teleconference will follow at 8:30 a.m. ET for management to discuss results and recent business activities. The company is a leader in healthcare-at-home solutions, catering to approximately 3.5 million patients annually across 700 locations. Their services include home medical equipment, diabetes supplies, oxygen therapy, and more, primarily serving Medicare, Medicaid, and commercial insurance beneficiaries.
AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced its participation in a fireside chat at the BofA Securities Home Care Conference on Monday, December 6, at 3:40 pm ET. Key executives, including Steve Griggs (CEO), Josh Parnes (President), and Jason Clemens (CFO), will represent the company. AdaptHealth serves around 3.5 million patients annually and offers a wide range of medical products and services across all 50 states, partnering with various healthcare providers to improve patient care.
AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced that CFO Jason Clemens will participate in a fireside chat at the BofA Securities Leveraged Finance Conference on Thursday, December 2 at 9:00 am ET. The company provides a range of services including home medical equipment and supplies, focusing on patient-centered care. With a network of over 700 locations, AdaptHealth serves approximately 3.5 million patients across all 50 states, offering solutions for chronic conditions and various medical needs.
AdaptHealth Corp. (NASDAQ: AHCO) announced that CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the Jefferies London Healthcare Conference. The presentation will be available on-demand starting Thursday, November 18, before market open, accessible via the Investors section of AdaptHealth’s website (www.adapthealth.com). AdaptHealth is a leader in providing healthcare-at-home solutions, reaching approximately 3.5 million patients annually across the U.S.
AdaptHealth Corp. (NASDAQ: AHCO) announced that its CEO Steve Griggs, President Josh Parnes, and CFO Jason Clemens will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on November 17 at 1:20 pm ET. A live webcast will be available through the Investors section of AdaptHealth’s website. The company is a leader in providing patient-centered, healthcare-at-home solutions, serving approximately 3.5 million patients annually across 716 locations in 47 states with a full suite of medical products.
AdaptHealth Corp. (NASDAQ: AHCO) reported a record net revenue of $653.3 million for Q3 2021, a 130% increase from the previous year, alongside a net income of $58.1 million, reversing a $51 million loss. Adjusted EBITDA surged 194% to $156.3 million. The company completed six acquisitions and has increased its fiscal 2021 revenue guidance to $2.41-$2.46 billion. For 2022, guidance is set at $2.70-$2.90 billion in revenue. Management is confident in driving organic growth through strategic acquisitions despite market challenges.